E
Lineage Cell Therapeutics, Inc. LCTX
$0.4817 -$0.0183-3.66%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -18.61M -20.11M -24.19M -23.66M -21.49M
Total Depreciation and Amortization 609.00K 633.00K 668.00K 696.00K 692.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 3.67M 3.69M 4.91M 5.25M 3.03M
Change in Net Operating Assets -8.77M -6.98M -3.40M -5.40M -10.80M
Cash from Operations -23.09M -22.77M -22.02M -23.11M -28.57M
Capital Expenditure -565.00K -291.00K -318.00K -524.00K -674.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -1.74M 5.09M 3.35M 31.51M 47.12M
Cash from Investing -2.31M 4.80M 3.03M 30.99M 46.45M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -54.00K -53.00K -52.00K -54.00K -54.00K
Issuance of Common Stock 36.11M 14.30M 15.13M 20.83M 6.71M
Repurchase of Common Stock -23.00K -222.00K -222.00K -222.00K -236.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -171.00K 86.00K 61.00K -112.00K 0.00
Cash from Financing 35.86M 14.11M 14.92M 20.44M 6.42M
Foreign Exchange rate Adjustments -95.00K 162.00K -216.00K -220.00K -250.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 10.36M -3.69M -4.28M 28.10M 24.06M
Weiss Ratings